Prahem Laboratories LLP

Denosumab 60 mg Injection is a monoclonal antibody that helps increase bone density by inhibiting bone resorption. It is commonly prescribed for osteoporosis in postmenopausal women and men at high fracture risk. The 1 ml injectable formulation offers convenient subcutaneous administration, ensuring effective and controlled dosing.

Denosumab 120 mg Injection is a monoclonal antibody used to treat bone complications in cancer patients and certain severe bone conditions. It works by inhibiting RANKL, a protein responsible for bone breakdown, helping to strengthen bones, reduce fractures, and prevent bone-related events in patients with cancer spreading to the bones (bone metastasis).